Journal of Adolescent Health
Volume 46, Issue 2, Supplement 2 , Pages S1-S3 , February 2010

The Importance of Overcoming Barriers to Adolescent Vaccination

References 

  1. Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006;55:1–23
  2. Marin M, Guris D, Chaves SS, et al. Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56:1–40
  3. Fiore AE, Shay DK, Broder K, et al. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2008;2008(57):1–60
  4. Centers for Disease Control and Prevention. Recommended immunization schedule for persons aged 7 through 18 years–United States, 2009. Available at: http://www.cdc.gov/vaccines/recs/schedules/downloads/child/2009/09_7-18yrs_schedule_pr.pdf. Accessed June 10, 2009.
  5. US Department of Health and Human Services. Objective 14–27: Increase routine vaccination coverage levels for adolescents. Available at: www.healthypeople.gov/document/html/objectives/14-27.htm. Accessed June 10, 2009.
  6. Centers for Disease Control and Prevention. Statistics and surveillance: July 2007 to June 2008 table data. Available at: http://www.cdc.gov/vaccines/stats-surv/nis/data/tables_0708.htm#overall. Accessed June 10, 2009.
  7. Vaccination coverage among adolescents aged 13-17years - United States, 2007. MMWR Morb Mortal Wkly Rep. 2008;57:1100–1103
  8. National, state, and local area vaccination coverage among adolescents aged 13-17 years–United States, 2008. MMWR Morb Mortal Wkly Rep. 2009;58:997–1001
  9. Mahoney MC, Pelton SI. Adolescents at risk: The case for meningococcal vaccine. J Adolesc Health. 2010;46:S4–S8
  10. Pelton SI. Meningococcal disease awareness: Clinical and epidemiological factors affecting management and prevention in adolescents. J Adolesc Health. 2010;46:S9–S15
  11. Harrison LH, Kreiner CJ, Shutt KA, et al. Risk factors for meningococcal disease in students in grades 9–12. Pediatr Infect Dis J. 2008;27:193–199
  12. Harrison LH, Pass MA, Mendelsohn AB, et al. Invasive meningococcal disease in adolescents and young adults. JAMA. 2001;286:694–699
  13. Kaplan SL, Schutze GE, Leake JA, et al. Multicenter surveillance of invasive meningococcal infections in children. Pediatrics. 2006;118:e979–e984
  14. Kaplan DW. Barriers and potential solutions to increasing immunization rates in adolescents. J Adolesc Health. 2010;46:S24–S33
  15. Lindley M, Orenstein W, Shen A, et al. National Vaccine Advisory Committee Vaccine Financing Working Group. Assuring Vaccination of Children and Adolescents without Financial Barriers: Recommendations from the National Vaccine Advisory Committee (NVAC). Washington, DC: U.S: Department of Health and Human Services; 2009;
  16. Kimmel SR. Adolescent vaccination: Physician challenges and solutions. J Adolesc Health. 2010;46:S16–S23
  17. Rand CM, Shone LP, Albertin C, et al. National health care visit patterns of adolescents: Implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med. 2007;161:252–259
  18. Freed GL, Cowan AE, Clark SJ. Primary care physician perspectives on reimbursement for childhood immunizations. Pediatrics. 2008;122:1319–1324
  19. Cohen NJ, Lauderdale DS, Shete PB, et al. Physician knowledge of catch-up regimens and contraindications for childhood immunizations. Pediatrics. 2003;111:925–932

PII: S1054-139X(09)00680-6

doi: 10.1016/j.jadohealth.2009.12.012

Journal of Adolescent Health
Volume 46, Issue 2, Supplement 2 , Pages S1-S3 , February 2010

Article Tools

* Image Usage & Resolution